chrisvoncsefalvay/vaers-outcomes huggingface dataset:
neck stiffness; left thumb joint pain; right arm pain around injection site; This is a spontaneous report from a contactable unspecified health professional. A 33-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EJ1685, expiry date: unknown, intramuscular at the right arm, from 22Dec2020 12:15 at a single dose for covid-19 immunization. The patient's medical history was not reported. Concomitant medication included simvastatin. On 22Dec2020 18:00 (Tuesday night), the patient experienced left thumb joint pain and right arm pain around injection site. On Wednesday, above issues continued. On 24Dec2020 18:00, Thursday, patient had neck stiffness. The joint pain all over was not severe but noticeable. Outcome of events was reported as unknown. There was no treatment or hospitalization involved. This case is non-serious.  No follow-up attempts are possible. No further information is expected. The information on the batch/lot number was obtained.
p/vax pt woke w/loud yelp; was stiff, back arched & not breathing; had several min of apnea; resolved spontaneously; no seizure activity
Inappropriate schedule of vaccine administered; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose after day 42) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose after day 42). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose after day 42) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
extremely high blood pressure; entire body filled with heat during high blood pressure episodes; Sore arm; itch all over body; feels terrible; can't eat anything but ice chips; Headache; A spontaneous report was received from a consumer concerning a 77-year old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sore arm, headache, itch all over body, extremely high blood pressure, feels terrible, can't eat anything but ice chips, and entire body filled with heat during high blood pressure episodes.  The patient's medical history was not provided. No relevant concomitant medications were reported. Additional suspected products included Prolia.  On Feb 2021, the patient received their second of two planned doses of mRNA-1273 (Batch Number not provided) intramuscularly for prophylaxis of COVID-19 infection.  Patient received Prolia injection 2 weeks after 2nd dose of Moderna's COVID-19 vaccination. Patient side effects reported since Prolia injection are itch all over body, extremely high blood pressure, feels terrible, can't eat anything but ice chips, and entire body filled with heat during high blood pressure episodes. Patient has been hospitalized twice over the past 2 weeks. Treatment for the events included steroids and amlodipine.  The patient received both scheduled doses of mRNA-1273; therefore, action taken with the drug in response to the events is not applicable.  The outcomes of the events were considered not recovered.; Reporter's Comments: Very limited information regarding these events has been provided at this time. The events are probably related to the Prolia injection received by the patient, which is known to cause these side effects.
Tuesday afternoon-didn't feel well, vision blurry & h/a;Thurs vision cleared but didn't feel well- h/a & fever;called MD & talked to nurse who told pt to come back in if not better Monday;took ASA Friday;Monday fatigue, h/a-seen by MD
flu; Initial information was received on 17-NOV-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional via social media.  This case involves a female patient (age unspecified) who flu (Influenza), when received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.   patient get a flu shot get the flu.  No laboratory data was provided.   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on the batch number for this case.
When preparing the MMR vaccine, instead of using the sterile water that is supplied with the vaccine, it was accidentally mixed with the Hib diluent, then administered. The nurses did not realize her mistake until after she gave the vaccines. Charge nurse, provider and family made aware shortly after realization from he nurse. Contacted pharmacy and various resources online. As of today. 7/11/2023, family has not reported any adverse reaction to this vaccine record.
I was busy forget to check the expired dated of vaccine I gave patient. No system report. No treatment. No adverse events.
No additional AE reported; Improperly stored vaccines administered; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information about medical history, concurrent conditions and concomitant therapies was not provided.        On 14-JUL-2023, the patient was vaccinated with hepatitis a vaccine, inactivated(VAQTA) (lot # X004813, expiration date 28-JUL-2024; strength, dose, route were not reported) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, recombinant human albumin (rHA) (M-M-R II) (lot # W017556, expiration date 07-JAN-2024; strength, dose, route were not reported) for prophylaxis. The temperature excursion was above 47 Fahrenheit degree (46.7 Fahrenheit degree) for 0 hours 25 minutes and 0 seconds (product storage error). There was no previous temperature excursion. No adverse event was reported.
Right Shoulder completely frozen; No right arm function/ loss of arm function; Started with stiff neck on right side; Pain in area of right arm where vaccine was given; Pain in shoulder/ pain in the front & back of shoulder; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 01Dec2021 as dose 3 (booster), single (Lot number: 32030BD), in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN, Anatomical location: Left Arm), for COVID-19 immunisation; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN, Anatomical location: Left Arm), for COVID-19 immunisation. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 09Jan2022, outcome "unknown", described as "Pain in area of right arm where vaccine was given"; ARTHRALGIA (non-serious) with onset 09Jan2022, outcome "unknown", described as "Pain in shoulder/ pain in the front & back of shoulder "; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 09Jan2022, outcome "unknown", described as "Started with stiff neck on right side"; MUSCULOSKELETAL DISORDER (non-serious) with onset 12Jan2022, outcome "unknown", described as "No right arm function/ loss of arm function"; PERIARTHRITIS (non-serious) with onset 12Jan2022, outcome "unknown", described as "Right Shoulder completely frozen".  Additional information: On 09Jan2022, started with stiff neck on right side with pain in arm & shoulder. Right Shoulder completely frozen on 12Jan2022. No right arm function on 12Jan2022 with severe pain in Right arm & shoulder. Majority of pain has been in the area of right arm where vaccine was given with pain in the front & back of shoulder too.
1/13 vaccination About 6 hours later, I started to feel hot, feverish, to feel really sick. I didn't think much about it. I went to work, thought was a sinus infection. Went home, and felt horrible.  1/14 didn't feel great but went to beach for my birthday. It went downhill from there. I got really really sick really fast.  1/17 rapid test; positive.  *still very fatigue, hard to describe the feeling. I get winded really easy.  **it really did affect me; 'put me in a dark place' / the mental part is really worse then the body part.
Pain stopped hurting; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Pain stopped hurting) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Pain stopped hurting). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Pain stopped hurting) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication reported included blood pressure medication.   No treatment medication details was reported.   This case was linked to MOD-2021-405067, MOD-2021-405734 (Patient Link).
Right leg redness, swelling 3 1/2 cm x 3 1/2 cm. Tender, mildly painful.
Information has been received from a physician concerning a 91 year old male patient who on 20-APR-2007, was vaccinated with ZOSTAVAX. On 09-MAY-2007, the patient got shingles. The patient sought medical attention at physician's office and phone called the physician. On an unspecified date, the patient recovered from shingles. Additional information has been requested.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Received vaccine past its 30-days; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2022 at 3:49 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 09-Feb-2022 at 3:49 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.    Treatment information was not reported.
This spontaneous report was received from a healthcare worker and refers to a 3 year old patient of unknown gender. The patient's concurrent conditions, past medical history were not reported. On 23-DEC-2015, the patient was vaccinated with an improperly stored M-M-R II (lot # K021151, expiry date 02-NOV-2016, dose, strength, vaccination site. dose number unspecified). Concomitant medications were not provided. No adverse effects were reported. Product quality complaint (PQC) was not reported. On 26-JAN-2016, a phone call was placed to the physician. The physician was unavailable at the time of call. The phone call was transferred to the Certified Medical Assistant (CMA). The C.M.A. was unable to place specific lot numbers for each of the reported vaccines that experienced a temperature excursion; M-M-R II, ROTATEQ and VAQTA, with the information already supplied for patient identifiers, date of birth and date of vaccination, at this time. The C.M.A. will need to review the records. This is one of the several reports received from the same reporter. Additional information has been requested.
Body aches; Muscles tired with a heavy; Flu like symptoms; Weak; Muscle aches; Nausea; Fatigued; Almost fainted; Felt dehydrated; Weak legs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRESYNCOPE (Almost fainted), DEHYDRATION (Felt dehydrated), MUSCULAR WEAKNESS (Weak legs), PAIN (Body aches) and MUSCLE FATIGUE (Muscles tired with a heavy) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced MUSCULAR WEAKNESS (Weak legs). On 10-Apr-2021, the patient experienced PRESYNCOPE (Almost fainted), DEHYDRATION (Felt dehydrated), PAIN (Body aches), MUSCLE FATIGUE (Muscles tired with a heavy), INFLUENZA LIKE ILLNESS (Flu like symptoms), ASTHENIA (Weak), MYALGIA (Muscle aches), NAUSEA (Nausea) and FATIGUE (Fatigued). At the time of the report, PRESYNCOPE (Almost fainted), DEHYDRATION (Felt dehydrated), MUSCULAR WEAKNESS (Weak legs), PAIN (Body aches), MUSCLE FATIGUE (Muscles tired with a heavy), INFLUENZA LIKE ILLNESS (Flu like symptoms), ASTHENIA (Weak), MYALGIA (Muscle aches), NAUSEA (Nausea) and FATIGUE (Fatigued) outcome was unknown. Not Provided          Concomitant medication not provided. Treatment was not included.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Tiredness chills vomiting lymph node pain and swelling swelling of the shot area with pain muscle pain lightheadedness nausea headache joint pain itching feeling unwell decreased appetite All went away within a couple weeks by themselves.  a month later vaginal spotting that resolved after about a week.  two weeks after neuropathy of the right big toe that has not gone away
When the technician was setting the Patient up to receive the Influenza Vaccine she reached into the refrigerator and accidently grabbed the wrong vaccine. Do to the amount of patient waiting she was moving too fast and missed the Five rights. She noticed the vaccines was not the correct one as soon as she pushed the plunger.
Patient complained of hard knot on injection site, pain, redness, chills later in evening. Ice and Ace bandage used.
1110 Moderna booster administered. 1135 patient c/o scratchy throat. Patient states that throat felt  scratchy, and tongue started to swell. Patient was instructed to sit in chair and had a decreased mental  status about one minute later. Patient was lethargic so staff assisted him to the floor and elevated his  legs. Patient stated that he ate chips prior to symptoms starting. 911 was called at 1140. Tongue  swelling worsened. EPI administered at 1142 into right thigh through jeans. Patient denies history of  allergies, no known drug, food, or environmental allergies. History of anxiety and depression. Patients  takes medications for anxiety/depression. No other meds taken. Patient denies SOB. No stridor,  wheezing, or hives noted. EMS arrived at 1148. Patient was able to stand with EMS assistance. Patient  was transported to the ED by EMS. Tongue still slightly swollen when patient left with EMS.
Felt off with poor appetite night of vaccine. Woke up the next am with fever 99.9. Arm sore at site
I received my Moderna vaccine on Friday, February 26, 2021 at approximately 1:00 pm at the Hospital. The next day Saturday, February 27, 2021 I woke up about 7:30 am. As i tried to made my way to the kitchen,I had a lot of trouble breathing and could hardly walk. I managed to get back to my bedroom to get my oxygen. I use oxygen at night, only , due to copd. (I had lung surgery in 2007 to remove the lower left lobe due to cancer.) I was very weak the entire day. The next day i continued to be short of breath and was s weak could hardly walk. On Monday, March 1,  was much worse. We called an ambulance and I was taken to Hospital. There were no beds. had to stay overnight in the emergency room. For the next few days,had multiple tests done. The doctors determined that had a lot of blood clots in both legs and needed surgery to remove the clots. was sent home for a few days. On March 9th went to Hospital to prepare for surgery. On March 10th, 2021.the doctors removed the blood clots from both legs and also had 2 blood transfusions. was released from hospital on March 14, 2021. As a result of blood clotting. I now take Eliquis, blood thinner, 2 times a day. I was supposed to received the second Moderna vaccine on March 26,2021, but declined due to th problem had with the first vaccine and on advice from most of my doctors. At the end of March i started having diarrhea. i was given medication but as soon as i finished the medication the diarrhea would come back, Apparently I got C-Diff from being In the hospital. This went on until July. On July 10,2021  had severe Diarrhea and was taken by ambulance to hospital. Medicaion did not work. On July 15, i had a colonoscpy and fecal implant. Finally, it seems to be working. All of this from getting a vaccine.  Hospital admit from March 9-March 14, 2021 Surgery and 6 days July 10-July 16,2021 Surgery
slight fatigued; weak; tested positive for COVID; body aches; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Mar-2021 and was forwarded to Moderna on 23-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), FATIGUE (slight fatigued), ASTHENIA (weak) and COVID-19 (tested positive for COVID) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PAIN (body aches). On 20-Mar-2021, the patient experienced COVID-19 (tested positive for COVID). On an unknown date, the patient experienced FATIGUE (slight fatigued) and ASTHENIA (weak). At the time of the report, PAIN (body aches), FATIGUE (slight fatigued), ASTHENIA (weak) and COVID-19 (tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was provided by the reporter as OTC supplements. Treatment information was provided as extra strength paracetamol.
On 11/1/00, child developed 3 areas on back, family initially dx'd as mosquito bites but by the 2nd, child now quite febrile. Had 6 on abdomen, few on back of leg and 10 on back. On Saturday, 150+ in mouth, ears, head, back, face and still febrile. Mom treated with oatmeal bath and by 11/10/00 were scabbed over.
This spontaneous report was received from a physician and refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions and drug reactions or allergies was provided. On 20-APR-2017, the patient was vaccinated with improperly stored dose of PROQUAD injection, lot # M042498 with expiration date 17-APR-2018, therapy type: human recombinant albumin (RHA) (dose and route of administration were not reported) reconstituted with properly stored sterile diluent (manufacturer unknown). Temperature excursion ranged from minus 14 to minus 10 degrees Celsius for 15 minutes and to 27 degrees Celsius for 30 minutes. There was no previous excursion. Digital data logger was used. Product quality complaint was not involved. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1710USA013407: US-009507513-1710USA013406: US-009507513-1710USA013408:
While in observation room client complain of mild tension to her throat. Client has her own benadryl 25mg she took orally.  Client denies difficulty breathing, airway clear, no s\s of distress.  Client in observation area being monitored,   talkative with staff and others, discharged after 30 minutes of being monitored, symptoms resolved client transported home by family.
PATIENT REPORTS THAT THE NEXT DAY AFTER RECEIVING THE INJECTION SHE NOTICED THAT AREA AT INJECTION SITE WAS WARM TO TOUCH. AREA SURROUNDING INJECTION SITE ERYTHEMATOUS AND APPROXIMATELY 3CM IN DIAMETER. AREA IS TENDER TO TOUCH AND PRURITIC. PATIENT HAS NOT TAKEN ANY MEDICATION FOR SYMPTOMS. NO PREVIOUS HX OF ADVERSE RXN TO INFLUENZA VACCINE.
This spontaneous report was received from a pharmacist refers to a 69-year-old female patient. Concurrent conditions included asthma, anxiety, depression and allergy to codeine. Historical drug included codeine. The patient was vaccinated with ZOSTAVAX (lot # H011048, expiration date 05-SEP-2013) subcutaneously, on 18-SEP-2012. Concomitant medications included ADVAIR, AMITIZA, paroxetine and phentermine. On 20-SEP-2012 the patient developed chills, sweats and dizziness. The patient recovered on 22-SEP-2012. No treatment was given for the events. No lab studies were performed. Patient sought medical attention by calling the pharmacist. Additional information has been requested.
Pt presented with a cough on 10/13 and was admitted to a local Medical Center on 12/3/22 due to abd pain lasting  2 weeks, pt was dx with a PE, UTI and sepsis.  Pt was previously living on the dementia care unit and was ambulatory, she is now on enhanced level care at the HCF, very debilitated and weak. Transfer requires 2 at times and sometimes, lift. She is w/c bound essentially w/ ulcers. Very confused.